Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-13-003194
Filing Date
2013-07-15
Accepted
2013-07-15 10:37:46
Documents
10
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q antr_10q.htm 10-Q 273923
2 CERTIFICATION antr_ex3101.htm EX-31.01 17172
3 CERTIFICATION antr_ex3102.htm EX-31.02 18279
4 CERTIFICATION antr_ex3201.htm EX-32.01 5641
  Complete submission text file 0001477932-13-003194.txt   1402196

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT antr-20130228.xml EX-101.INS 55560
6 XBRL TAXONOMY EXTENSION SCHEMA antr-20130228.xsd EX-101.SCH 10432
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antr-20130228_cal.xml EX-101.CAL 11036
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antr-20130228_def.xml EX-101.DEF 10745
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE antr-20130228_lab.xml EX-101.LAB 67546
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antr-20130228_pre.xml EX-101.PRE 48688
Mailing Address 4405 POWELL AVE MONTREAL A8 H4P 1E5
Business Address 4405 POWELL AVE MONTREAL A8 H4P 1E5 514 967 4372
Antaga International Corp (Filer) CIK: 0001501112 (see all company filings)

EIN.: 680678499 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-170091 | Film No.: 13967283
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries